New to Meducation?
Sign up
Already signed up?
Log In
Add To Boards
Add
Upvote
0
CPD Tracker
00:00
FDA OKs Topical Drug Combo (Enstilar) for Plaque Psoriasis
Enstilar combines calcipotriene and betamethasone dipropionate in a foam formulation for topical treatment of plaque psoriasis in adults.
#Dentistry
x
#Dermatology
x
#Psoriasis
x
#Therapeutics
x
Help by adding tags...
New antibody therapy dramatically improves psoriasis symptoms in clinical trial
- Only a single treatment produced what researchers describe as 'rapid, substantial, and durable clinical...
0
5
Trending
Bacteriology Map: Cocci, Bacili and Spiral
- An incredible diagram on bacteriology. Remember a lot of hard details quickly and easily!
531
30024
Cosentyx (secukinumab) is the first IL-17A inhibitor to be available for moderate to severe plaque psoriasis in the UK
- Novartis Pharmaceuticals UK Limited (Novartis) has announced that Cosentyx (secukinumab) is available for use in the UK for the treatment of moderate to severe plaque psoriasis in adults who...
0
6
FDA approves new psoriasis drug Cosentyx
- The U.S. Food and Drug Administration has approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis.
0
7
Psoriasis: Otezla (apremilast), receives European marketing authorisation in two therapeutic indications
- Celgene UK has announced that the European Commission has licensed Otezla, the Company's oral selective inhibitor of phosphodiesterase 4 (PDE4), in two therapeutic...
0
6
US regulatory submission of the first aerosol foam for psoriasis
- LEO Pharma announced it has submitted a New Drug Application to the US Food and Drug Administration (FDA) for calcipotriene/betamethasone dipropionate aerosol foam 0,005%/0,064% for the...
0
4
Cranial Nerves - Anatomy, Clinical Signs and Study Tips
- This is a teaching resource that aids the student in memorisation of the Cranial Nerves, their anatomical path and function. Additionally, it stimulates a clinical approach to the functions of t...
1186
40270
